Organisms engineered with novel techniques of synthetic biology are more affordable as it increases the use of genetically modified microorganisms for various industrial applications and cuts down the cost of research. This is leading to the greater utilization of synthetic biology technologies and products by researchers across the globe.
Synthetic biology research has witnessed immense multidisciplinary development over the years. The strides in the synthetic biology market has, to say the least, piggybacked on continuous advances in genetic engineering technologies. The drive has stemmed from the incessant urge of various proponents of the relatively new discipline to design and redesign biological components and systems. These systems in turn have been key enablers and accelerators of numerous novel research in industrial processes and health care sector.
Governments around the world and policy makers have laid great emphasis on targeted research programs through public policies. Especially in developed nations, sizable investments have grown rapidly for setting sustainable bio-engineered processes backed by government funding, such as in the U.S. and the U.K. The prospects are vast. The numbers do not lie—according to a projection by Transparency Market Research, the synthetic biology will reach worth of US$13.4 bn, globally, by 2019-end.
Multidisciplinary Research Leverage Bioengineering Processes for Advancing Healthcare
The profound potential that synthetic biology, alongside genetic engineering and systems biology, has been key driver for interest of industry players in the market. Proponents pin hopes on addressing food and energy challenges, providing options to conventional petrochemicals, and bring probiotic health products to the world. Perhaps, the most transformative impact is the health care industry. A growing body of multidisciplinary research has been focusing on leveraging the potential of synthetic biology, particularly gene-based methods, to advance personalized healthcare and treatments to insect-borne diseases. Advances in genetic engineering methods will be a bellwether of expanding prospects of the synthetic biology market.
Get a Glimpse of the In-Depth Analysis through our Synthetic Biology Market Report Brochure
Strides in Data-Driven Bio-Engineering Methods Open New Paradigm
A series of scientific and technologies have underpinned capacity development in bioengineering processes in the synthetic biology market. For instance, considerable strides have been witnessed in DNA synthesis, in terms of both reduced cost and increased capabilities. The market has prospered on the back of inter alia biological assembly tools, state-of-the-art modelling techniques, and adoption of automated and data-driven bio-engineering methods.
One of the prominent trend has been the adoption of bio-design automation. This has progressed on the back of the expanding array of software environments, machine learning, and computer algorithms. For instance, researchers using new array of have been able to expand libraries of combinatorial variants. Machine learning has enabled them to save time and find optimal solutions. A key application of such automation systems has been in the design of bioprospecting and pathways in general and that of genes and proteins in specific. Growing popularity of combinatorial library design is shaping a new paradigm for the synthetic biology market. The demand for creating complex biochemical pathways based on automation will keep the prospects lucrative.
Meanwhile, emerging prospects in the synthetic biology market have laid bare various ethical concerns and have attracted regulatory attention, leading to the need for responsible and informed research. On the other hand, growing quantum of public as well as private investments are focusing on taking several of the results from labs to real-world applications. This provides a consistent momentum to the expansion of the synthetic biology market.
Advances in Genome Engineering Techniques to Reflect Well on Developed Markets
Regionally, North America has contributed sizable revenues to the global market over the past few years. In 2016, its share in the global synthetic biology market was highest. Incessant advances made in genome engineering techniques and rapid adoption of bio-design automation among industry players have been reinforcing the potential of this regional market. On the other hand, Europe has shown vast potential in recent years, The strides in this region is fueled by favorable regulations and spiraling public and private R&D investments on synthetic biology. A great deal of efforts are centered on leveraging bioengineering processes for novel applications in environment, healthcare, and energy sectors.
Growing Understanding about the Benefits of Cannabis to Spur Demand for CBD Hemp Oil
Global CBD hemp oil market was valued at more than US$ 950.0 Mn in 2017 and is projected to surpass US$ 2.5 Bn by 2026, expanding at a compound annual growth rate (CAGR) of more than 11% from 2018 to 2026.
Increasing Application Segments are Helping to Push Growth of Global Nanomedicine Market
Global Nanomedicine Market was valued at USD 78.54 billion in 2012 and is expected to reach a value of USD 177.60 billion in 2019, growing at a CAGR of 12.3% from 2013 to 2019
